Select for export Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal Obstacles Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX SSRN Electronic Journal 2017-11-02 Mason Marks OpenAlex Published psilocybin AnxietyAddictionMechanism of Action Review Article More
Select for export Navigating Psychedelic Medicines through (Inter)national Regulation Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Northumbria Research Link (Northumbria University) 2017-07-01 Jonathan Nash OpenAlex Published psilocybin Clinical TrialToxicity Clinical Trial More
Select for export Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/srep46421 PubMed 28422113 Copy citation Copy BibTeX Scientific Reports 2017-04-18 Schartner MM, Carhart-Harris RL, Barrett AB, Seth AK, Muthukumaraswamy SD. Europe PMC Published psilocybin ConsciousnessObservational StudyHealthy Volunteers Observational Study More
Select for export The Development and Regulation of Psychedelic Medicines Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX Northumbria Research Link (Northumbria University) 2017-04-05 Jonathan Nash OpenAlex Published psilocybin AddictionReceptor PharmacologyVeterans Other More
Select for export The fibrinolytic system: A new target for treatment of depression with psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.mehy.2017.01.013 PubMed 28236848 Copy citation Copy BibTeX Unknown journal 2017-01-22 Idell RD, Florova G, Komissarov AA, Shetty S, Girard RB, Idell S. Europe PMC Published psilocybin DepressionNeuroplasticityNeurogenesis Other More
Select for export Exploring Hallucinogen Pharmacology and Psychedelic Medicine with Zebrafish Models. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/zeb.2016.1251 PubMed 27002655 Copy citation Copy BibTeX Unknown journal 2016-03-21 Kyzar EJ, Kalueff AV. Europe PMC Published psilocybin DepressionAnxietyPTSD Animal Study More
Select for export Legal highs: staying on top of the flood of novel psychoactive substances. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125314559539 PubMed 26240749 Copy citation Copy BibTeX Unknown journal 2015-03-31 Baumeister D, Tojo LM, Tracy DK. Europe PMC Published psilocybin AddictionPharmacologyReview Article Review Article More
Select for export Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881114568040 PubMed 25670401 Copy citation Copy BibTeX Journal of psychopharmacology (Oxford, England) 2015-02-28 Majić T, Schmidt TT, Gallinat J PubMed Published psilocybin AnxietyAddictionOCD Clinical Trial More
Select for export Drug models of schizophrenia. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/2045125314557797 PubMed 25653831 Copy citation Copy BibTeX Therapeutic advances in psychopharmacology 2015-01-31 Steeds H, Carhart-Harris RL, Stone JM PubMed Published psilocybin AddictionReview ArticleDrug Interactions Review Article More
Select for export Can psychedelic compounds play a part in drug dependence therapy? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjp.bp.114.148031 PubMed 25561484 Copy citation Copy BibTeX Unknown journal 2014-12-31 Sessa B, Johnson MW. Europe PMC Published psilocybin General Other More
Select for export Recreational use, analysis and toxicity of tryptamines. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2174/1570159x13666141210222409 PubMed 26074742 Copy citation Copy BibTeX Unknown journal 2014-12-31 Tittarelli R, Mannocchi G, Pantano F, Romolo FS. Europe PMC Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Review Article More
Select for export EPA-0137 - EEG power spectra and connectivity changes in animal serotonergic and glutamatergic models of psychosis - implications for treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s0924-9338(14)77609-6 Copy citation Copy BibTeX European Psychiatry 2013-12-31 Tomáš Páleníček, Filip Tylš, M. Fujáková, Anna Kubešová, Pavlína Nováková, L. Kadeřábek OpenAlex Published psilocybinpsilocin Brain ImagingReceptor PharmacologyBiomarkers Other More
Select for export Dimethyltryptamine (DMT): prevalence, user characteristics and abuse liability in a large global sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113513852 PubMed 24284475 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-11-26 Winstock AR, Kaar S, Borschmann R. Europe PMC Published psilocybin Observational StudyAbuse Liability Observational Study More
Select for export Methoxetamine (MXE)--a phenomenological study of experiences induced by a "legal high" from the internet. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2013.803647 PubMed 24175493 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2013-06-30 Kjellgren A, Jonsson K. Europe PMC Published psilocybin AnxietyAddictionConsciousness Qualitative Study More
Select for export Psychiatry's next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/0269881113494107 PubMed 23784738 Copy citation Copy BibTeX Journal of Psychopharmacology 2013-06-18 Carhart-Harris RL, Brugger S, Nutt DJ, Stone JM. Europe PMC Published psilocybin Depression Other More
Select for export Single treatments that have lasting effects: some thoughts on the antidepressant effects of ketamine and botulinum toxin and the anxiolytic effect of psilocybin. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1503/jpn.120128 Copy citation Copy BibTeX Фундаментальные исследования (Fundamental Research) 2013-02-28 Young SN. Europe PMC Published psilocybin DepressionAnxietyMechanism of Action Clinical Trial More
Select for export The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-012-2811-0 PubMed 22836372 Copy citation Copy BibTeX Psychopharmacology 2012-07-26 Schmidt A, Kometer M, Bachmann R, Seifritz E, Vollenweider F. Europe PMC Published psilocybin Receptor PharmacologyEmotional Processing Other More
Select for export Substance use initiation: the role of simultaneous polysubstance use. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/j.1465-3362.2012.00470.x PubMed 22612987 Copy citation Copy BibTeX Drug and Alcohol Review 2012-05-20 Olthuis JV, Darredeau C, Barrett SP. Europe PMC Published psilocybin AddictionAdolescentsSafety Other More
Select for export Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/npp.2011.261 PubMed 22030715 Copy citation Copy BibTeX Unknown journal 2011-10-25 Schmidt A, Bachmann R, Kometer M, Csomor PA, Stephan KE, Seifritz E Europe PMC Published psilocybin Mechanism of ActionReceptor PharmacologyConsciousness Other More
Select for export Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.2217/pgs.10.171 PubMed 21332315 Copy citation Copy BibTeX Unknown journal 2011-01-31 Meyer MR, Maurer HH. Europe PMC Published psilocybinpsilocin AddictionPharmacologySafety Other More
